← All indications
Colitis
Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
Subtype terms (4)
More specific conditions that are subtypes of Colitis in the MeSH hierarchy.
- Colitis, Ischemic
1 drug experimental
- Colitis, Microscopic
6 drugs (4 approved, 2 experimental)
- Colitis, Ulcerative
411 drugs (148 approved, 263 experimental)
- Proctocolitis
2 drugs (1 approved, 1 experimental)
Drugs by status
Approved for this indication (2)
Phase 4 trials (1)
Phase 3 trials (5)
Phase 2 trials (17)
Phase 1 trials (5)
Organizations
Organization Involved with Phase 4 Indications (79)
- Abbott
- AbbVie
- Takeda
- Shire
- Bausch Health Companies
- Merck
- Pfizer
- Sanofi
- Celltrion
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Huazhong University of Science and Technology
- University of Pennsylvania
- Baylor University
- Boston University
- Centro Hospitalar Lisboa Ocidental
- University of London
- Diakonhjemmet Hospital
- University of Washington
- Grupo de Estudo da Doença Inflamatória Intestinal
- Guangzhou Medical University
- Imelda Hospital, Bonheiden
- Kliniken im Naturpark Altmuehltal
- McMaster University
- Nanjing Medical University
- Northwestern University
- Ohio State University
- Postgraduate Institute of Medical Education and Research
- Universidad Autonoma de Madrid
- University of Groningen
- University of Melbourne
- +49 more
Organization Involved with Phase 3 Indications (98)
- Zeria Pharmaceutical
- Alizyme
- Eisai
- Facet Biotech
- Theravance
- Celgene
- Millennium Pharmaceuticals
- Bristol-Myers Squibb
- Galapagos NV
- Roche
- Astellas
- Gilead Sciences
- AstraZeneca
- Centocor
- Eli Lilly
- Tillotts Pharma
- Genzyme
- PDL BioPharma
- Arena Pharmaceuticals
- EMET Pharmaceuticals, LLC
- INC Research
- InDex Pharmaceuticals
- Kissei Pharmaceuticals
- Leadiant Biosciences, Inc.
- Parexel
- Shield Therapeutics
- Vifor Inc.
- Boehringer Ingelheim
- EA Pharma Co., Ltd.
- Eagle Pharmaceuticals, Inc.
- +68 more
Organization Involved with Phase 2 Indications (165)
- Abivax S.A.
- Incyte
- AltruBio
- ActoGeniX
- Amgen
- Merck Serono
- Genentech
- MedImmune
- Biogen
- Romark
- AM-Pharma
- Novartis
- Allergan
- Athersys, Inc
- Bayer
- BioLineRx, Ltd.
- Cerimon Pharmaceuticals
- GlaxoSmithKline
- Hamilton Health Sciences Corporation
- Harbor Therapeutics
- Hemay Pharmaceutical PTY. LTD.
- Holy Stone Healthcare Co., Ltd
- Immune Pharmaceuticals
- Ionis Pharmaceuticals, Inc.
- Kyowa Hakko Kirin
- Lexicon Pharmaceuticals
- Lipid Therapeutics GmbH
- LG
- Lycera Corp.
- Natrogen Therapeutics International, Inc
- +135 more
Organization Involved with Phase 1 Indications (28)
- Sirtris Pharmaceuticals
- Human Genome Sciences
- Aptevo Therapeutics
- Wyeth
- Avaxia Biologics
- NuBiyota
- VHsquared Ltd.
- Assembly Biosciences
- Swiss National Science Foundation
- Seattle Children's Hospital
- China Academy of Chinese Medical Sciences
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- University of Oslo
- University of Southern California
- University of Zurich
- Stony Brook University
- Wenzhou Medical University
- University of California, Irvine
- University of California, San Francisco
- University of Colorado, Denver
- Alliance Foundation Trials
- Oklahoma Foundation for Digestive Research
- University of Montreal
- Washington University in St. Louis
- University of Colorado
- Wakunaga Pharmaceutical Co., Ltd.
- Nuvisan Pharma Services
- Provention Bio, Inc.
Organization Involved with Other Experimental Indications (30)
- VSL Pharmaceuticals
- United States Army
- Maastricht University
- Atlantic Health System
- Cedars-Sinai Medical Center
- Hong Kong Baptist University
- New York University
- Norwegian University of Science and Technology
- Oakland University
- Radboud University
- University of Dundee
- University of Hamburg
- Utrecht University
- Wageningen University
- Chinese University of Hong Kong
- Universita' Cattolica del Sacro Cuore
- OpenBiome
- The University of Hong Kong
- Pennsylvania State University
- University of Nantes
- OSF HealthCare
- Arla Foods
- Mauna Kea Technologies
- NASPGHAN Foundation
- Tenovus Scotland
- Government of Finland
- Keimyung University
- Fondazione Schena
- University Clinic Zvezdara
- University Clinic Dr Dragisa Misovic-Dedinje